+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Drugs By Therapeutic Area Market Research Reports

H1N1 Infection - Pipeline Insight, 2025 - Product Thumbnail Image

H1N1 Infection - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
Factor VIII Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

Factor VIII Inhibitor - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Adenosine A1 Receptor Agonist - Pipeline Insight, 2025 - Product Thumbnail Image

Adenosine A1 Receptor Agonist - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Plasminogen Activator Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

Plasminogen Activator Inhibitor - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Glucagon Receptor Antagonist - Pipeline Insight, 2025 - Product Thumbnail Image

Glucagon Receptor Antagonist - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Kainate Receptor Antagonist - Pipeline Insight, 2025 - Product Thumbnail Image

Kainate Receptor Antagonist - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Adenosine A2A Receptor Antagonist - Pipeline Insight, 2025 - Product Thumbnail Image

Adenosine A2A Receptor Antagonist - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Alpha V Beta 3/5/6 Integrin Antagonist - Pipeline Insight, 2025 - Product Thumbnail Image

Alpha V Beta 3/5/6 Integrin Antagonist - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Alpha V Beta 3 Integrin Antagonist - Pipeline Insight, 2025 - Product Thumbnail Image

Alpha V Beta 3 Integrin Antagonist - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Myostatin Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

Myostatin Inhibitor - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Alpha-1 Agonist - Pipeline Insight, 2025 - Product Thumbnail Image

Alpha-1 Agonist - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
VAP-1 Inhibitors - Pipeline Insight, 2025 - Product Thumbnail Image

VAP-1 Inhibitors - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Cholecystokinin Receptor (CCK) Antagonist - Pipeline Insight, 2025 - Product Thumbnail Image

Cholecystokinin Receptor (CCK) Antagonist - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Angiopoietin Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

Angiopoietin Inhibitor - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Renin Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

Renin Inhibitor - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
From
Beta Selective Thyroid Hormone Receptor Agonist - Pipeline Insight, 2025 - Product Thumbnail Image

Beta Selective Thyroid Hormone Receptor Agonist - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Beta Receptor Antagonist - Pipeline Insight, 2025 - Product Thumbnail Image

Beta Receptor Antagonist - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 90 Pages
  • Global
From
Angiotensin Modulators - Pipeline Insight, 2025 - Product Thumbnail Image

Angiotensin Modulators - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Non Selective COX Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

Non Selective COX Inhibitor - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Loading Indicator

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more